← All diseases Cancer

Liver cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the most robust evidence (78)Meta-analysis (34)Treatment guideline (5)Systematic review (18)Randomized trial (14)Phase 3 study (7)Clinical trial (608)Review article (448)Early study (phase 1 or 2) (26)Laboratory or animal research (164)Case report (110)Commentary or editorial (69)Retracted publication (8)Concerns have been raised (1) Studies currently recruiting participants only (41)

Filter

Publications and studies (3377)

• Mangiferin Attenuated Diethynitrosamine-Induced Hepatocellular Carcinoma in Sprague-Dawley Rats via Alteration of Oxidative Stress and Apoptotic Pathway. (2019/01/01) ♡
• Induction of Autophagic Death of Human Hepatocellular Carcinoma Cells by Armillaridin from Armillaria mellea. (2019/01/01) ♡
• The use of cell-free DNA in the diagnosis of HCC. (2019/01/01) ♡
• Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells. (2019/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Medical oncologists must get more involved in systemic treatment. (2019/01/01) ♡
• Stereotactic Body Radiotherapy Combined with Transcatheter Arterial Chemoembolization versus Stereotactic Body Radiotherapy Alone as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres. (2018/12/31) ♡
• Structural Characterization and Antitumor Activity of Polysaccharides from Kaempferia galanga L. (2018/12/30) ♡
• Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development. (2018/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein. (2018/12/16) ♡
• Diacylglycerol kinase γ predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma. (2018/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PRO: Patients With Hepatitis C Virus With Pretreatment Metavir Stage 3 Fibrosis Do Not Require Hepatocellular Carcinoma Surveillance After Sustained Virological Response. (2018/12/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. All Patients With Advanced Fibrosis Should Continue to Be Screened for Hepatocellular Carcinoma After Sustained Virological Response of Hepatitis C Virus. (2018/12/14) ♡
• Long-Term Zinc Supplementation Improves Liver Function and Decreases the Risk of Developing Hepatocellular Carcinoma. (2018/12/10) ♡
• Identification of IFITM3 and MGAT1 as novel interaction partners of BRI3 by yeast two-hybrid screening. (2018/12/10) ♡
• Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress. (2018/12/09) ♡
• An inflammatory-CCRK circuit drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. (2018/12/06) ♡
• Liver reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. (2018/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice or Hepatocarcinoma Xenograft. (2018/12/01) ♡
• Cryptotanshinone (Dsh-003) from Salvia miltiorrhiza Bunge inhibits prostaglandin E2-induced survival and invasion effects in HA22T hepatocellular carcinoma cells. (2018/12/01) ♡
• Interferon-α Combined With Herbal Compound “Songyou Yin” Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review. (2018/12/01) ♡
• Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. (2018/12/01) ♡
• Oral oxymatrine for hepatitis B cirrhosis: A systematic review protocol. (2018/12/01) ♡
• Liraglutide modulates gut microbiota and reduces NAFLD in obese mice (2018/12/01) ♡
• Ozone detoxification of patulin in aqueous solution and cytotoxic evaluation using human hepatic carcinoma cells. (2018/12/01) ♡
• Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma (2018/12/01) ♡
• Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc-driven hepatocellular carcinoma. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. De Novo Primary Liver Cancer After Liver Transplantation: A French National Study on 15803 Patients. (2018/12/01) ♡
• Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma. (2018/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Managing Diabetes and Liver Disease Association. (2018/12/01) ♡
• Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease. (2018/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Dietary Tomato Powder Inhibits High-Fat Diet-Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage Enzymes. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter: is microwave ablation superior to radiofrequency ablation for early-stage hepatocellular carcinoma? (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nonalcoholic Fatty Liver Disease: Status Quo. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sarcopenia and chronic liver diseases. (2018/12/01) ♡
• Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma. (2018/12/01) ♡
• The impact of direct-acting antiviral therapy for hepatitis C on hepatocellular carcinoma risk. (2018/12/01) ♡
• Successful recanalization of acute extensive portal vein thrombosis by aspiration thrombectomy and thrombolysis via an operatively placed mesenteric catheter: a case report. (2018/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Controversy in the Treatment of Localized Hepatocellular Carcinoma. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. TACE-Ablate Approach to Treatment of a Solitary HCC. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. HCC in Cirrhotics With Retained Liver Function and Absent Portal Hypertension: Still a Surgical Disease. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The Case for Proton Beam Therapy. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. SBRT as a Favored Ablative Therapy for Stage I HCC. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Emerging Role for Systemic Therapy in Earlier Stages of HCC. (2018/12/01) ♡
• WDR1 predicts poor prognosis and promotes cancer progression in hepatocellular carcinoma. (2018/12/01) ♡
• HCRP1, ID4 and Glypican-3: an optimal panel of biomarkers for diagnosis of hepatocellular carcinoma. (2018/12/01) ♡
• LncRNA CERNA2 is an independent predictor for clinical prognosis and is related to tumor development in gastric cancer. (2018/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.